Role of blood-brain barrier in Alzheimer's disease

Z Cai, PF Qiao, CQ Wan, M Cai… - Journal of Alzheimer's …, 2018 - content.iospress.com
The blood-brain barrier (BBB) is involved in the pathogenesis of Alzheimer's disease (AD).
BBB is a highly selective semipermeable structural and chemical barrier which ensures a …

Pharmacological effects of icariin

C He, Z Wang, J Shi - Advances in pharmacology, 2020 - Elsevier
Icariin (ICA) is a principal active component from traditional Chinese medicine Epimedium
grandiflorum. To explain its traditional medical usages by modern science, a variety of …

Gene-SGAN: discovering disease subtypes with imaging and genetic signatures via multi-view weakly-supervised deep clustering

Z Yang, J Wen, A Abdulkadir, Y Cui, G Erus… - Nature …, 2024 - nature.com
Disease heterogeneity has been a critical challenge for precision diagnosis and treatment,
especially in neurologic and neuropsychiatric diseases. Many diseases can display multiple …

From stroke to dementia: a comprehensive review exposing tight interactions between stroke and amyloid-β formation

R Goulay, L Mena Romo, EM Hol… - Translational Stroke …, 2020 - Springer
Stroke and Alzheimer's disease (AD) are cerebral pathologies with high socioeconomic
impact that can occur together and mutually interact. Vascular factors predisposing to …

The contribution of β-amyloid, Tau and α-synuclein to blood–brain barrier damage in neurodegenerative disorders

YC Wu, TA Bogale, J Koistinaho, M Pizzi, T Rolova… - Acta …, 2024 - Springer
Central nervous system (CNS) accumulation of fibrillary deposits made of Amyloid β (A β),
hyperphosphorylated Tau or α-synuclein (α-syn), present either alone or in the form of mixed …

Cognitive impairment caused by hypoxia: from clinical evidences to molecular mechanisms

X Wang, L Cui, X Ji - Metabolic Brain Disease, 2022 - Springer
Hypoxia is a state of reduced oxygen supply and excessive oxygen consumption. According
to the duration of hypoxic period, it can be classified as acute and chronic hypoxia. Both …

Brain‐Penetrating and Disease Site‐Targeting Manganese Dioxide‐Polymer‐Lipid Hybrid Nanoparticles Remodel Microenvironment of Alzheimer's Disease by …

E Park, LY Li, C He, AZ Abbasi, T Ahmed… - Advanced …, 2023 - Wiley Online Library
Finding effective disease‐modifying treatment for Alzheimer's disease remains challenging
due to an array of factors contributing to the loss of neural function. The current study …

An outline for the pharmacological effect of icariin in the nervous system

J Jin, H Wang, X Hua, D Chen, C Huang… - European Journal of …, 2019 - Elsevier
Icariin is a major active component of the traditional herb Epimedium, also known as Horny
Goat Weed. It has been extensively studied throughout the past several years and is known …

Role of neuron and glia in Alzheimer's disease and associated vascular dysfunction

S Bandyopadhyay - Frontiers in aging neuroscience, 2021 - frontiersin.org
Amyloidogenicity and vascular dysfunction are the key players in the pathogenesis of
Alzheimer's disease (AD), involving dysregulated cellular interactions. An intricate balance …

Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease

Q Lu, RL Powles, S Abdallah, D Ou, Q Wang, Y Hu… - PLoS …, 2017 - journals.plos.org
Continuing efforts from large international consortia have made genome-wide epigenomic
and transcriptomic annotation data publicly available for a variety of cell and tissue types …